Skin Rejuvenation with IPL Rosacea

August 31, 2012 14:57
Skin Rejuvenation with IPL Rosacea

Rosacea. It turn s your skin red, causes skin sensitivity and sometimes acne. Some patients complain of painful, irritated eyes and thickening of the facial skin.  Rosacea is a common skin condition which can be extremely uncomfortable. Dermatologists often use oral and topical medications to treat rosacea, although for many patients, symptoms persist.

Doctors have been using lasers to treat rosacea with good success since the 1980’s.  A laser relative, the IPL (Intense Pulsed Light)machine has provided significant results for rosacea patients.  The IPL uses intense light waves, similar to a laser to treat symptoms such as

Dilated blood vessels
Persistent redness
Acne-like breakouts

How Does IPL Work for Rosacea?

The intense pulsed light from the IPL penetrates into the skin and breaks down the tiny dilated blood vessels that cause much of the redness associated with rosacea.  Patients who are treated with the IPL for rosacea usually see a marked improvement in the appearance of redness, dilated blood vessels, flushing and even the occurrence of acne-like break outs.  Treatment usually consists of one complete facial treatment every 3 weeks for up to five treatments.

Is IPL Right for You?

While IPL treatment for rosacea has a track record of good success, it may not work well

on every patient.  It is important to maintain reasonable expectations and to understand that treatment results may not be the same for every patient.  Treating rosacea and rosacea symptoms with IPL is not covered by insurance.

The first step in preparing for IPL treatment for rosacea is to schedule a consultation with our licensed medical esthetician in order to determine whether this treatment option is right for you.  Once a treatment plan has been established, you can move forward with your first treatment.

If you enjoyed this Post, Sign up for Newsletter

(And get daily dose of political, entertainment news straight to your inbox)

Rate This Article
(0 votes)